Repetera-utvalda Flashcards
(168 cards)
EANO rec:
H3 K27M-mutant diffuse midline glioma, WHO grade 4
- Radiotherapy only.
This tumour type includes the majority of brainstem, thalamic and spinal diffuse gliomas in children and adults. Surgical options are limited and benefits from treatment options beyond radiotherapy have not been established because these tumours are rare and have not been studied in dedicated trials. In these tumours, the MGMT promoter is usually unmethylated. The prognosis of patients with this tumour type is poor.
EANO rec:
H3.3 G34-mutant diffuse hemispheric glioma, WHO grade 4
- Surgery if feasible and Chemoradiotherapy.
These tumours mostly occur in adolescents and young adults and the MGMT promoter is more often methylated than unmethylated. These tumours were previously classified as IDH-wild-type glioblastomas and, thus, a reasonable treatment approach for such patients is chemoradiotherapy
Important stages of Karnofsky performance scale to remember
80-100 - able to carry on normal activity and to work. No special care needed.
50-70 - Unable to work, able to live at home and care for most personal needs; varying amount of assistance needed.
0-40 - Unable to care for self, requires equivalent of institutional or hospital care; disease may be progressing rapidly.
What molecular signs make an astrocytoma grade 4?
- IDH mut AND
- loss of ATRX (ATRX mut) or p53 mutation AND
- CDKN2A/B deletion
What is MGMT?
o6-metylguanihn-DNA-metyltransferase
Something is special about some spinal ependymoma and they even got their own name. What?
MYCN amplified.
What is the definition of an oligodendroglioma in WHO CNS 4?
- 1p/19q codeletion
- IDH mutation
- astrocytic appearance
So, A Diffuse glioma is deemed IDH wt.
What more is needed for diagnosis Glioblastoma IDH wt CNS WHO grade 4?
One or more of the following:
* microvascular proliferation
* Necrosis
* TERTp mutation
* EGFR gene amplificantion
* +7/-10
What molecular signs make an IDH mutant astrocytoma grade 4 if the tumor also have microvascular proliferation and/or necrosis?
An ATRX mutation or a p53 mutation.
what alkylating cyt is used for methylated MGMT tumors?
Temozolomid.
What dubbeldeletion is strongly connected to oligodendroglioma?
1p19q deletion.
What clinical traits are 1p19q codeletion associated with?
better prognosis and better response to cyt treatment. (uns)
What is IDH?
the enzyme isocitratedehydrogenas 1 and 2.
What tumor is H3, G34 mutation associated to?
(pediatric) diffuse hemispheric glioma, H3G34. (WHO grade 4)
What tumor is H3K27 mutations associated to?
(pediatric) diffuse midline glioma, H3K27. (WHO grade 4, more aggressive than H3G34)
What is K-67?
A nuclear antigen that gives information of proliferation. Proliferation index is % positive cell nuclei in the tumor. High=aggressive
What does a P53 mutation suggest?
An astrocytic tumor. ( in oposition to oligodendroglioma)
When is 1p/19q deletion tested?
In all IDH mutated glioma grade II and III w kept ATRX expression.
When is ATRX immunohistochemistry done?
In all astrocytoma and oligodendroglioma, if nuclear ATRX is lost, it is NOT an oligodendroglioma.
When is TERT promotor mutaion controlled?
In IDH wt glioma with grade II or III histology
Loss of ———–expression is a strong indication of a astrocytoma and not a oligodendroglioma.
ATRX
Mutation of ———is a strong indication of Astrocytoma and not Oligodendroglioma
p53
What alteration warants a astrocytoma IDH mutant to go from grade 2/3 to grade 4 independent of microvascular proliferations and necrosis?
Homozygous CDKN2A/B
What is bevacizumab?
An angiogenes inhibiting agent.